Machine Learning-Supported Diagnosis of Small Blue Round Cell Sarcomas Using Targeted RNA Sequencing
Copyright © 2024 Association for Molecular Pathology and American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved..
DUX4 translocation events, the most common CIC rearrangement, is challenging. Here, we present a machine-learning approach to support SBRCS diagnosis that relies on gene expression profiles measured via targeted sequencing. The analyses on a curated cohort of 69 soft-tissue tumors showed markedly distinct expression patterns for SBRCS subgroups. A random forest classifier trained on Ewing sarcoma and CIC-rearranged cases predicted probabilities of being CIC-rearranged >0.9 for CIC-rearranged-like sarcomas and <0.6 for other SBRCSs. Testing on a retrospective cohort of 1335 routine diagnostic cases identified 15 candidate CIC-rearranged tumors with a probability >0.75, all of which were supported by expert histopathologic reassessment. Furthermore, the multigene random forest classifier appeared advantageous over using high ETV4 expression alone, previously proposed as a surrogate to identify CIC rearrangement. Taken together, the expression-based classifier can offer valuable support for SBRCS pathologic diagnosis.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:26 |
|---|---|
| Enthalten in: |
The Journal of molecular diagnostics : JMD - 26(2024), 5 vom: 01. Apr., Seite 387-398 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Schlieben, Lea D [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Biomarkers, Tumor |
|---|
| Anmerkungen: |
Date Completed 22.04.2024 Date Revised 22.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jmoldx.2024.02.002 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM368853896 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM368853896 | ||
| 003 | DE-627 | ||
| 005 | 20240422232134.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240229s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jmoldx.2024.02.002 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1383.xml |
| 035 | |a (DE-627)NLM368853896 | ||
| 035 | |a (NLM)38395409 | ||
| 035 | |a (PII)S1525-1578(24)00046-1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Schlieben, Lea D |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Machine Learning-Supported Diagnosis of Small Blue Round Cell Sarcomas Using Targeted RNA Sequencing |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 22.04.2024 | ||
| 500 | |a Date Revised 22.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2024 Association for Molecular Pathology and American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved. | ||
| 520 | |a Small blue round cell sarcomas (SBRCSs) are a heterogeneous group of tumors with overlapping morphologic features but markedly varying prognosis. They are characterized by distinct chromosomal alterations, particularly rearrangements leading to gene fusions, whose detection currently represents the most reliable diagnostic marker. Ewing sarcomas are the most common SBRCSs, defined by gene fusions involving EWSR1 and transcription factors of the ETS family, and the most frequent non-EWSR1-rearranged SBRCSs harbor a CIC rearrangement. Unfortunately, currently the identification of CIC::DUX4 translocation events, the most common CIC rearrangement, is challenging. Here, we present a machine-learning approach to support SBRCS diagnosis that relies on gene expression profiles measured via targeted sequencing. The analyses on a curated cohort of 69 soft-tissue tumors showed markedly distinct expression patterns for SBRCS subgroups. A random forest classifier trained on Ewing sarcoma and CIC-rearranged cases predicted probabilities of being CIC-rearranged >0.9 for CIC-rearranged-like sarcomas and <0.6 for other SBRCSs. Testing on a retrospective cohort of 1335 routine diagnostic cases identified 15 candidate CIC-rearranged tumors with a probability >0.75, all of which were supported by expert histopathologic reassessment. Furthermore, the multigene random forest classifier appeared advantageous over using high ETV4 expression alone, previously proposed as a surrogate to identify CIC rearrangement. Taken together, the expression-based classifier can offer valuable support for SBRCS pathologic diagnosis | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Transcription Factors |2 NLM | |
| 650 | 7 | |a Oncogene Proteins, Fusion |2 NLM | |
| 650 | 7 | |a Biomarkers, Tumor |2 NLM | |
| 700 | 1 | |a Carta, Maria Giulia |e verfasserin |4 aut | |
| 700 | 1 | |a Moskalev, Evgeny A |e verfasserin |4 aut | |
| 700 | 1 | |a Stöhr, Robert |e verfasserin |4 aut | |
| 700 | 1 | |a Metzler, Markus |e verfasserin |4 aut | |
| 700 | 1 | |a Besendörfer, Manuel |e verfasserin |4 aut | |
| 700 | 1 | |a Meidenbauer, Norbert |e verfasserin |4 aut | |
| 700 | 1 | |a Semrau, Sabine |e verfasserin |4 aut | |
| 700 | 1 | |a Janka, Rolf |e verfasserin |4 aut | |
| 700 | 1 | |a Grützmann, Robert |e verfasserin |4 aut | |
| 700 | 1 | |a Wiemann, Stefan |e verfasserin |4 aut | |
| 700 | 1 | |a Hartmann, Arndt |e verfasserin |4 aut | |
| 700 | 1 | |a Agaimy, Abbas |e verfasserin |4 aut | |
| 700 | 1 | |a Haller, Florian |e verfasserin |4 aut | |
| 700 | 1 | |a Ferrazzi, Fulvia |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Journal of molecular diagnostics : JMD |d 1999 |g 26(2024), 5 vom: 01. Apr., Seite 387-398 |w (DE-627)NLM111386683 |x 1943-7811 |7 nnns |
| 773 | 1 | 8 | |g volume:26 |g year:2024 |g number:5 |g day:01 |g month:04 |g pages:387-398 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jmoldx.2024.02.002 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 26 |j 2024 |e 5 |b 01 |c 04 |h 387-398 | ||